VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,106 | +6.7% | 262 | +9.2% | 0.00% | – |
| Q3 2023 | $1,037 | -9.6% | 240 | +37.9% | 0.00% | – |
| Q2 2023 | $1,147 | -1.8% | 174 | 0.0% | 0.00% | – |
| Q1 2023 | $1,168 | -81.1% | 174 | -79.2% | 0.00% | -100.0% |
| Q4 2022 | $6,171 | -31.4% | 835 | -3.1% | 0.00% | -50.0% |
| Q3 2022 | $9,000 | 0.0% | 862 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $9,000 | +12.5% | 857 | +14.6% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | -33.3% | 748 | -4.7% | 0.00% | -25.0% |
| Q4 2021 | $12,000 | -7.7% | 785 | +4.5% | 0.00% | -20.0% |
| Q3 2021 | $13,000 | -27.8% | 751 | -10.8% | 0.01% | -28.6% |
| Q2 2021 | $18,000 | 0.0% | 842 | -30.3% | 0.01% | 0.0% |
| Q1 2021 | $18,000 | +38.5% | 1,208 | +13.9% | 0.01% | +40.0% |
| Q4 2020 | $13,000 | +30.0% | 1,061 | +0.7% | 0.01% | +25.0% |
| Q3 2020 | $10,000 | +25.0% | 1,054 | +34.4% | 0.00% | 0.0% |
| Q2 2020 | $8,000 | -11.1% | 784 | -13.5% | 0.00% | -20.0% |
| Q1 2020 | $9,000 | – | 906 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |